Resources

Type of publications
Regions
Diseases

5255 results found

2024 ∙ Tsang, T. K. Sullivan, S. G. Huang, X. Wang, C. Wang, Y. Nealon, J. Yang, B. Ainslie, K. E. C. Cowling, B. J.

Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Duradoni, M. Tosti, A. E. Colombini, G. Masti, F. Licata, A. L. Zanobini, P. Materassi, L. Guazzini, A.

Promoters and Barriers of Vaccine Hesitancy

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Properzi, S. Sepioni, M. S. Carestia, R. Cervelli, G. de Waure, C.

Promoting Vaccinations in Pregnancy: Results of a Systematic Literature Review of Italian Initiatives

  • Europe
  • Italy
  • Pregnant women
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ferdinands, J. M. Blanton, L. H. Alyanak, E. Chung, J. R. Trujillo, L. Taliano, J. Morgan, R. L. Fry, A. M. Grohskopf, L. A.

Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Abuelazm, M. T. Elzeftawy, M. A. Kamal, M. A. Badr, H. Gamal, M. Aboulgheit, M. Abdelazeem, B. Abd-elsalam, S. Abouzid, M.

Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials

  • All age groups
  • Malaria
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Ryoo, S. Choi, M. Choi, N. K. Shin, H. S. Woo, J. H. Park, B. J. Oh, S.

Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review

  • Western Pacific
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Rizzo, M. Gattino, S. Trombetta, T. Calandri, E. De Piccoli, N.

Psychosocial dimensions of vaccine hesitancy: A systematic review

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ de Fougerolles, T. R. Baissas, T. Perquier, G. Vitoux, O. Crepey, P. Bartelt-Hofer, J. Bricout, H. Petitjean, A.

Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives

  • Europe
  • France
  • Italy
  • Spain
  • United Kingdom
  • All age groups
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Olszewska, B. Zarycza Nowicki, R. J. Sokołowska-Wojdyło, M.

Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Guo, J. Chen, X. Guo, Y. Liu, M. Li, P. Tao, Y. Liu, Z. Yang, Z. Zhan, S. Sun, F.

Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies

  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...